The PE Ratio as of May 2025 (TTM) for IXICO plc (PHYOF) is -1.40

According to IXICO plc’s latest financial reports and current stock price. The company's current PE Ratio is -1.40. This represents a change of -50.11% compared to the average of -2.81 of the last 4 quarters.

IXICO plc (PHYOF) Historical PE Ratio (quarterly & annually)

How has PHYOF PE Ratio performed in the past?

The mean historical PE Ratio of IXICO plc over the last ten years is 10.99. The current -1.40 PE Ratio has changed -1373.36% with respect to the historical average. Over the past ten years (40 quarters), PHYOF's PE Ratio was at its highest in in the September 2019 quarter at 27.50. The PE Ratio was at its lowest in in the February 2005 quarter at -11.65.

IXICO plc (PHYOF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of IXICO plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IXICO plc (PHYOF) Average PE Ratio

How has PHYOF PE Ratio performed in the past?

The current PE Ratio of IXICO plc (PHYOF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IXICO plc (PHYOF) PE Ratio vs. Peers

How is PHYOF’s PE Ratio compared to its peers?

IXICO plc’s PE Ratio is greater than iTeos Therapeutics, Inc. (-2.20), less than Kiromic BioPharma, Inc. (-0.09), greater than Icosavax, Inc. (-15.78), less than Cardio Diagnostics Holdings, Inc. (-1.01), greater than Annexon, Inc. (-1.71), less than NRx Pharmaceuticals, Inc. (0), less than BiomX Inc. (-0.95), less than Lexaria Bioscience Corp. (-0.25), greater than Aditxt, Inc. (-2.02), less than Corcept Therapeutics Incorporated (-0.01), less than OmniAb, Inc. (55.03), greater than Pliant Therapeutics, Inc. (-2.43), less than Phathom Pharmaceuticals, Inc. (-0.41), less than Cabaletta Bio, Inc. (-0.90), less than Eyenovia, Inc. (-0.51), less than Reviva Pharmaceuticals Holdings, Inc. (-0.02), less than Cidara Therapeutics, Inc. (-0.91), less than Fortress Biotech, Inc. (-1.08), less than Selecta Biosciences, Inc. (-0.71), greater than Ocugen, Inc. (-6.69), greater than Jaguar Health, Inc. (-3.61), less than Tonix Pharmaceuticals Holding Corp. (-0.07), less than Hepion Pharmaceuticals, Inc. (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than null (-0.00),

Build a custom stock screener for IXICO plc (PHYOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IXICO plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IXICO plc (PHYOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IXICO plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.